Differential sensitivity of human epithelial cells to Pseudomonas aeruginosa exoenzyme S.
Exoenzyme S (ExoS) is an ADP-ribosyltransferase produced and directly translocated into eukaryotic cells by the opportunistic pathogen Pseudomonas aeruginosa. Model systems that allow bacterial translocation of ExoS have found ExoS to have multiple effects on eukaryotic cell function, affecting DNA synthesis, actin cytoskeletal structure, and cell matrix adherence. To understand mechanisms underlying differences observed in cell sensitivities to ExoS, we examined the effects of bacterially translocated ExoS on multiple human epithelial cell lines. Of the cell lines examined, confluent normal kidney (NK) epithelial cells were most resistant to ExoS, while tumor-derived cell lines were highly sensitive to ExoS. Analysis of the mechanisms of resistance indicated that cell association as well as an intrinsic resistance to morphological alterations were associated with increased resistance to ExoS. Conversely, increased sensitivity to ExoS appeared to be linked to epithelial cell growth, with tumor cells capable of undergoing non-contact-inhibited, anchorage-independent growth all being sensitive to ExoS, and NK cells becoming sensitive to ExoS when subconfluent and growing. Consistent with the possibility that growth-related, actin-based structures are involved in sensitivity to ExoS, scanning electron microscopy revealed cellular extensions from sensitive, growing cells to bacteria, which were not readily evident in resistant cells. In all studies, the severity of effects of ExoS on cell function directly correlated with the degree of Ras modification, indicating that sensitivity to ExoS in some manner related to the efficiency of ExoS translocation and its ADP-ribosylation of Ras. Our results suggest that factors expressed by growing epithelial cells are required for the bacterial contact-dependent translocation of ExoS; as normal epithelial cells differentiate into polarized confluent monolayers, expression of these factors is altered, and cells in turn become more resistant to the effects of ExoS.
McGuffie
E M
EM
Department of Experimental Oncology, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Fraylick
J E
JE
Hazen-Martin
D J
DJ
Vincent
T S
TS
Olson
J C
JC
D036002:ADP Ribose Transferases / Q000276:immunology* / Q000633:toxicity; D001426:Bacterial Proteins / Q000276:immunology / Q000633:toxicity; D001427:Bacterial Toxins; D002454:Cell Differentiation / Q000276:immunology; D016764:Cell Polarity; D004847:Epithelial Cells / Q000187:drug effects / Q000276:immunology / Q000382:microbiology* / Q000473:pathology; D006801:Humans; D007113:Immunity, Innate; D011550:Pseudomonas aeruginosa / Q000276:immunology* / Q000378:metabolism
D001426:Bacterial Proteins; D001427:Bacterial Toxins; D036002:ADP Ribose Transferases; C444820:exoenzyme S